ArticlePharmaceutical research2016

Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP.

Shufan Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.